Home Search Abstracts View Session E-mail Abstract Author


Session 23 Oral Abstracts
Pathogenesis of Acute and Chronic Infection
Session Day and Time: Tuesday, 10 am - 12:15 pm
Presentation Time: 10:30 am
Room: Room 403


65
Microbial Translocation Is a Cause of Systemic Immune Activation in Chronic HIV Infection
Jason Brenchley*1, D Price1, T Schacker2, G Silvestri3, O Lambotte4, A Landay5, L Picker6, M Lederman7, S Deeks8, and D Douek1
1Vaccine Res Ctr, NIAID, NIH Bethesda, MD, US; 2Univ of Minnesota, Minneapolis, US; 3Univ of Pennsylvania, Philadelphia, US; 4Ctr Univ Hosp Bicetre, France; 5Rush Med Coll, Chicago, IL, US; 6Oregon Hlth and Sci Univ, Portland, US; 7Case Western Reserve Univ, Cleveland, OH, US; and 8Univ of California, San Francisco, US

Background:  Chronic activation of the immune system is a hallmark of progressive HIV infection and better predicts disease outcome than plasma viral load, yet its etiology remains obscure. Several studies suggest that the integrity of the gastrointestinal immune system is devastated after the acute phase. This may allow increased translocation of luminal microbial products and consequently increased systemic immune activation.

Methods:  We measured microbial translocation, as determined by plasma LPS levels, in a cohort of >300 subjects, including HIV-uninfected individuals, chronically infected individuals before and after HAART, long-term nonprogressors, as well as simian immunodeficiency virus (SIV)-infected rhesus macaques and sooty mangabeys. In addition, we measured T-cell activation, monocyte responsiveness, and plasma levels of several soluble factors associated with immune activation.

Results:  Chronic progressive HIV infection is associated with increasing levels of microbial translocation across the gastrointestinal tract, as defined by plasma LPS. Translocated LPS is bioactive in vivo and directly correlates with several independent aspects of innate and adaptive immune activation. In addition, low levels of natural anti-LPS antibodies during chronic HIV-infection were consistently associated with higher levels of immune activation. HAART only partially reduces microbial translocation. Finally, while chronically SIV-infected rhesus macaques also exhibit signs of microbial translocation this does not occur in nonpathogenic SIV infection of sooty mangabeys.

Conclusions:  These studies strongly suggest that translocation of microbial products from a damaged gastrointestinal tract is an important cause of immune activation in chronic HIV disease. Moreover, these data provide novel directions for therapeutic interventions that modify the consequences of HIV infection. The aim would be to prevent or reduce the propagation of HIV at mucosal surfaces, to restore the immunological and epithelial integrity of the mucosal barrier, and to block pathways through which microbial products cause systemic immune activation.